CUG252
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CUG252, covering 2025-02-20 to 2025-02-20. Get the full timeline:
Most recent: Clinical Trial Update: A Phase Ia Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneously Administered CUG252 in Normal Healthy Volunteers [Phase 1]